Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (7637)	11/4/1998 3:27:00 PM
From: Robert K.	Read Replies (2) \| Respond to of 17367

devils advocate> if the hospital recieves X dollars for Y indications, then will the docs use it knowing they will get a loss on their patient. Or conversely will the benefits outweight the costs. Bid 10,000 shares to buy at 3.5 before the close. Good sign.

To: Bluegreen who wrote (7637)	11/4/1998 7:55:00 PM
From: jackie	Read Replies (1) \| Respond to of 17367

Bluegreen, Your words brought some very vivid and bad memories to the fore. When my son was two, he contracted subacute bacterial endocarditis with a serious tricuspid insufficiency (his valve was leaking.) Of course, that first night we didn't know what the problem was. We just had a very sick baby with elevated white blood counts, low grade chronic fever, and general listlessness. No one knew what was going one. The night was a blur of requests from the doctors for permission to do one risky procedure after another. Tapping the pericardial sac, spinal tap, etc. Almost every case of "fever, unknown etiology" will suggest a spinal tap. Several friends and acquaintances with serious trauma or fevers have had spinals done. These were almost always done to rule out meningitis. Believe me, under those circumstances costs mean nothing if it will minimize danger. Jack